| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |